Eicosanoid metabolism in human platelets is modified by albumin.
Dadaian
M
M
Department of Woman and Child Health, Karolinska Hospital, Stockholm, Sweden.
Westlund
P
P
D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid / Q000097:blood; D001092:Arachidonate 12-Lipoxygenase / Q000097:blood; D016718:Arachidonic Acid / Q000097:blood; D001095:Arachidonic Acids / Q000494:pharmacology; D001667:Binding, Competitive; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D015777:Eicosanoids / Q000097:blood*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004963:Estrenes / Q000494:pharmacology; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000494:pharmacology; D066298:In Vitro Techniques; D007700:Kinetics; D016859:Lipoxygenase Inhibitors; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D015539:Platelet Activation / Q000187:drug effects / Q000502:physiology; D011760:Pyrrolidinones / Q000494:pharmacology; D012709:Serum Albumin / Q000378:metabolism*; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors
D001095:Arachidonic Acids; D015777:Eicosanoids; D004791:Enzyme Inhibitors; D004963:Estrenes; D006893:Hydroxyeicosatetraenoic Acids; D016859:Lipoxygenase Inhibitors; D011760:Pyrrolidinones; D012709:Serum Albumin; C081565:arachidonyltrifluoromethane; C060229:1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione; D016718:Arachidonic Acid; C022022:5-hydroxy-6,8,11,14-eicosatetraenoic acid; D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; C025984:15-hydroxy-5,8,11,13-eicosatetraenoic acid; D001092:Arachidonate 12-Lipoxygenase; D010741:Phospholipases A; D010738:Type C Phospholipases